Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 252
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL01
NCT00198991
2.
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL03
NCT00199004
3.
Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 15
Other
GMALL05
NCT00199082
4.
Efficacy of G-CSF-Priming in Elderly AML Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 60
Other
AML-elderly 01/99 Trial
NCT00199147
5.
Oral Zinc Therapy for the Prevention of Mucositis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
18 to 70
Other
SHEBA-06-4196-MKM-CTIL
NCT00449592
6.
Study Treatment to Low Risk ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 and under
Other
LAL-BR/2001
NCT00526175
7.
German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL04
NCT00199017
Last Modified:
10/22/2007
 
First Published:
12/1/1998
8.
Phase II/III Randomized Study of Bleomycin, Cisplatin, and Etoposide (BEP) Versus Bleomycin, Cisplatin, Etoposide, and Paclitaxel (T-BEP) in Men With Intermediate Prognosis Germ Cell Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
16 to 50
Other
EORTC-30983
NCT00003643
Last Modified:
6/9/2008
 
First Published:
7/1/1999
9.
Phase II/III Study of Standard and Novel Conditioning Therapy and Allogeneic Blood or Marrow Transplantation in Patients With Severe Aplastic Anemia or Hematologic Malignancy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
4 to 65
Other
RPCI-RP-9815
NCI-V99-1527, NCT00003816, RP 98-15
10.
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Active
18 to 70
Other
UARK 2003-26
NCT00090493
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute